Bio-Techne (TECH) Non Operating Investment Income (2022 - 2023)
Bio-Techne (TECH) recorded quarterly Non Operating Investment Income of $283000.0 in Q3 2023, up 141.56% quarter-over-quarter from -$681000.0 in Q2 2023, and down 99.43% on a YoY basis from $49.8 million in Q3 2022.
Bio-Techne (TECH) Non Operating Investment Income (2022 - 2023) Analysis & Trends
Bio-Techne's Non Operating Investment Income history runs 2 years deep, the most recent figure standing at $283000.0 for Q3 2023.
- In Q3 2023, Non Operating Investment Income fell 99.43% year-over-year to $283000.0; the TTM figure through Jun 2024 stood at $283000.0 (down 99.43% YoY), while the FY2024 annual figure was $283000.0, down 99.43% from the prior year.
- Non Operating Investment Income was $283000.0 for Q3 2023 at Bio-Techne, up from -$681000.0 in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $49.8 million in Q3 2022 to a low of -$681000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 235,807.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 230,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 283,000.00 |
| Sep 30, 2023 | 283,000.00 |
| Jun 30, 2023 | -681,000.00 |
| Jun 30, 2023 | -681,000.00 |
| Mar 31, 2023 | 314,000.00 |
| Mar 31, 2023 | 314,000.00 |
| Dec 31, 2022 | -74,000.00 |
| Dec 31, 2022 | -74,000.00 |
| Sep 30, 2022 | 49.77 Mn |
| Sep 30, 2022 | 49.77 Mn |